SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-08-07
👔
AGENUS INC
@AGEN_InsiderForm 4 Filing: O'Day Steven J Acquires (Grant) shares of $AGEN
STOCK AWARD / GRANT
⚡ MATERIALITY: 1/10
corporate issuer
AGENUS INC
Ticker: $AGEN
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-08-05
Shares: 100,000
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, O'Day Steven J, holds the title of Chief Medical Officer at AGENUS INC.
On 2026-08-05, the insider transacted 100,000 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
O'Day Steven J (Chief Medical Officer) was granted $0 of $AGEN
Post-Transaction Position: 100,000 shares
SEC Accession No: 0001193125-26-339996 (CIK: 1845281)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.